Last Name

Alyssa Marie Schlenz

InstitutionMedical University of South Carolina
AddressP.O. Box MSC 561
RT 390
Rutledge Tower Building - 135 Rutledge Ave.
vCardDownload vCard

    Collapse Overview 
    Collapse studies/trials
    Collapse overview
    Dr. Schlenz is a pediatric psychologist with expertise in sickle cell disease and other chronic health conditions.She is particularly interested in understanding how biomedical and psychosocial factors work together to influence health outcomes in children. Dr. Schlenz’s work includes procedural and recurrent pain, health-related quality of life, and developmental issues in pediatric sickle cell disease. She provides psychological services to children with sickle cell disease,including developmental screening, neuropsychological evaluation, and brief psychosocial consultation.
    Collapse keywords
    pediatrics, sickle cell disease

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kanter J, Phillips S, Schlenz AM, Mueller M, Dooley M, Sirline L, Nickel R, Brown RC, Hilliard L, Melvin CL, Adams RJ. Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study. J Pediatr Hematol Oncol. 2021 Mar 31. PMID: 33625093.
      View in: PubMed
    2. Noisette ML, Phillips S, Schlenz AM, Mueller M, Kanter J. Changes in Care Delivery for Children With Sickle Cell Anemia During the COVID-19 Pandemic. J Pediatr Hematol Oncol. 2020 Nov 23. PMID: 33235147.
      View in: PubMed
    3. Phillips S, Schlenz AM, Mueller M, Melvin C, Adams RJ, Kanter J. Practice patterns for neuroimaging and transfusion therapy for management of neurologic complications in sickle cell anemia: DISPLACE consortium. Pediatr Blood Cancer. 2020 11; 67(11):e28569. PMID: 32894002.
      View in: PubMed
    4. Schlenz AM, Phillips S, Mueller M, Melvin C, Adams RJ, Kanter J. Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium. Pediatr Blood Cancer. 2020 04; 67(4):e28172. PMID: 31925913.
      View in: PubMed
    5. Maxwell SL, Schlenz AM, Kanter J. Health-related Quality of Life in Children With Sickle Cell Disease Undergoing Chronic Red Cell Transfusion Therapy. J Pediatr Hematol Oncol. 2019 05; 41(4):307-312. PMID: 31026251.
      View in: PubMed
    6. Schlenz AM, Hayes J, Mueller M, Phillips S, Adams RJ, Kanter J. Incomplete implementation of guideline-based stroke prevention therapy in sickle cell disease. Am J Hematol. 2018 09; 93(9):E222-E224. PMID: 29905391.
      View in: PubMed
    7. Schatz J, Schlenz AM, Smith KE, Roberts CW. Predictive validity of developmental screening in young children with sickle cell disease: a longitudinal follow-up study. Dev Med Child Neurol. 2018 05; 60(5):520-526. PMID: 29488622.
      View in: PubMed
    8. Schatz J, Schlenz A, Reinman L, Smith K, Roberts CW. Developmental Screening in Pediatric Sickle Cell Disease: Disease-Related Risk and Screening Outcomes in 4 Year Olds. J Dev Behav Pediatr. 2017 Oct; 38(8):654-662. PMID: 28816916.
      View in: PubMed
    9. Schlenz AM, Schatz J, Roberts CW. Examining Biopsychosocial Factors in Relation to Multiple Pain Features in Pediatric Sickle Cell Disease. J Pediatr Psychol. 2016 Sep; 41(8):930-40. PMID: 26869665.
      View in: PubMed
    10. Schlenz AM, Boan AD, Lackland DT, Adams RJ, Kanter J. Needs Assessment for Patients with Sickle Cell Disease in South Carolina, 2012. Public Health Rep. 2016 Jan-Feb; 131(1):108-16. PMID: 26843676.
      View in: PubMed
    11. Schlenz AM, Carpenter LA, Bradley C, Charles J, Boan A. Age Differences in Emergency Department Visits and Inpatient Hospitalizations in Preadolescent and Adolescent Youth with Autism Spectrum Disorders. J Autism Dev Disord. 2015 Aug; 45(8):2382-91. PMID: 25739694.
      View in: PubMed
    12. Schatz J, Schlenz AM, McClellan CB, Puffer ES, Hardy S, Pfeiffer M, Roberts CW. Changes in coping, pain, and activity after cognitive-behavioral training: a randomized clinical trial for pediatric sickle cell disease using smartphones. Clin J Pain. 2015 Jun; 31(6):536-47. PMID: 25503599.
      View in: PubMed
    13. Smith TP, Schlenz AM, Schatz JC, Maitra R, Sweitzer SM. Modulation of pain in pediatric sickle cell disease: understanding the balance between endothelin mediated vasoconstriction and apelin mediated vasodilation. Blood Cells Mol Dis. 2015 Feb; 54(2):155-9. PMID: 25486928.
      View in: PubMed
    14. Schlenz AM, McClellan CB, Mark TR, McKelvy AD, Puffer E, Roberts CW, Sweitzer SM, Schatz JC. Sensitization to acute procedural pain in pediatric sickle cell disease: modulation by painful vaso-occlusive episodes, age, and endothelin-1. J Pain. 2012 Jul; 13(7):656-65. PMID: 22633685.
      View in: PubMed
    15. Schlenz AM, Schatz J, McClellan CB, Roberts CW. Responsiveness of the PedsQL to pain-related changes in health-related quality of life in pediatric sickle cell disease. J Pediatr Psychol. 2012 Aug; 37(7):798-807. PMID: 22467881.
      View in: PubMed
    16. Schlenz AM, Schatz J, McClellan CB, Sweitzer SM, Roberts CW. Information-seeking coping behaviors during painful procedures in African-American children with sickle cell disease. Pain Manag Nurs. 2013 Sep; 14(3):e54-8. PMID: 23972871.
      View in: PubMed
    Schlenz's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description